Linda Dirven

7.9k total citations · 1 hit paper
179 papers, 3.3k citations indexed

About

Linda Dirven is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Linda Dirven has authored 179 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Genetics, 57 papers in Pulmonary and Respiratory Medicine and 37 papers in Rheumatology. Recurrent topics in Linda Dirven's work include Glioma Diagnosis and Treatment (81 papers), Rheumatoid Arthritis Research and Therapies (36 papers) and Cancer-related cognitive impairment studies (35 papers). Linda Dirven is often cited by papers focused on Glioma Diagnosis and Treatment (81 papers), Rheumatoid Arthritis Research and Therapies (36 papers) and Cancer-related cognitive impairment studies (35 papers). Linda Dirven collaborates with scholars based in Netherlands, United States and United Kingdom. Linda Dirven's co-authors include Martin Taphoorn, Johan A F Koekkoek, Jaap C. Reijneveld, Martin Klein, T. Huizinga, Cornelia F Allaart, Martin J. van den Bent, Michael Weller, Willem F. Lems and J.J. Heimans and has published in prestigious journals such as Annals of Internal Medicine, Neurology and Cancer.

In The Last Decade

Linda Dirven

168 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioma

2024 173 citations Michael Weller, Patrick Y. Wen et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Dirven Netherlands	31	1.5k	808	657	630	497	179	3.3k
Nicole J. Ullrich United States	40	1.4k 0.9×	585 0.7×	335 0.5×	229 0.4×	609 1.2×	132	4.3k
Brian V. Nahed United States	35	1.3k 0.9×	1.1k 1.4×	650 1.0×	849 1.3×	141 0.3×	176	5.5k
Maura Massimino Italy	41	2.5k 1.6×	1.7k 2.1×	337 0.5×	1.0k 1.6×	1.1k 2.2×	346	6.2k
Tina Young Poussaint United States	43	2.2k 1.4×	667 0.8×	196 0.3×	402 0.6×	634 1.3×	148	4.6k
Raja B. Khan United States	33	1.5k 1.0×	1.0k 1.3×	116 0.2×	327 0.5×	1.4k 2.7×	115	3.5k
N.J. Tarbell United States	28	1.1k 0.7×	891 1.1×	149 0.2×	418 0.7×	505 1.0×	81	2.8k
M. Fatih Okcu United States	38	1.2k 0.8×	1.6k 1.9×	309 0.5×	723 1.1×	871 1.8×	148	3.8k
Hans‐Jakob Steiger Germany	44	1.5k 1.0×	1.5k 1.8×	228 0.3×	401 0.6×	221 0.4×	258	6.2k
Maurizio Salvati Italy	44	2.7k 1.8×	2.1k 2.6×	522 0.8×	690 1.1×	232 0.5×	286	6.1k
Hee‐Won Jung South Korea	48	2.2k 1.4×	1.4k 1.7×	452 0.7×	578 0.9×	152 0.3×	296	8.0k

Countries citing papers authored by Linda Dirven

Since Specialization

Citations

This map shows the geographic impact of Linda Dirven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Dirven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Dirven more than expected).

Fields of papers citing papers by Linda Dirven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Dirven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Dirven. The network helps show where Linda Dirven may publish in the future.

Co-authorship network of co-authors of Linda Dirven

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Dirven. A scholar is included among the top collaborators of Linda Dirven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Dirven. Linda Dirven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asogwa, Ogechukwu A, Johan A F Koekkoek, Hanneke Zwinkels, et al.. (2025). Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale. Quality of Life Research. 34(10). 2809–2819.

Grønvold, Mogens, Johannes M. Giesinger, Linda Dirven, et al.. (2025). The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes. European Journal of Cancer. 231. 116064–116064.

Weller, Michael, Patrick Y. Wen, Susan M. Chang, et al.. (2024). Glioma. Nature Reviews Disease Primers. 10(1). 33–33. 173 indexed citations breakdown →

Boele, Florien, Matthias Preusser, Émilie Le Rhun, et al.. (2024). Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectives. Neuro-Oncology Practice. 11(4). 484–493. 2 indexed citations

Boele, Florien, Caroline Hertler, Paula R. Sherwood, et al.. (2024). Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group. Neuro-Oncology Practice. 12(1). 19–33. 2 indexed citations

Meer, Pim B. van der, Linda Dirven, Marta Fiocco, et al.. (2023). Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy. Neurology. 100(14). e1488–e1496. 2 indexed citations

Reijneveld, Jaap C., Peter M. van de Ven, Martin J. van den Bent, et al.. (2023). Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials. European Journal of Cancer. 186. 38–51. 5 indexed citations

Musoro, Jammbe, Corneel Coens, Mirjam A. G. Sprangers, et al.. (2023). Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European Journal of Cancer. 188. 171–182. 64 indexed citations

Coopmans, Eva C, Amir H. Zamanipoor Najafabadi, Linda Dirven, et al.. (2023). Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of Neuro-Oncology. 161(2). 357–370. 1 indexed citations

10.

Dirven, Linda, Jeroen de Bresser, Rúben Dammers, et al.. (2023). The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor- and treatment-related factors. Neuro-Oncology Advances. 5(1). vdad056–vdad056. 1 indexed citations

11.

Coomans, Marijke B, Linda Dirven, Neil K. Aaronson, et al.. (2022). Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period. Neuro-Oncology. 24(12). 2159–2169. 13 indexed citations

12.

Retzer, Ameeta, Stephanie Sivell, Annmarie Nelson, et al.. (2022). Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study. BMJ Open. 12(9). e057712–e057712. 7 indexed citations

13.

Gillespie, Conor S., Amir H. Zamanipoor Najafabadi, Linda Dirven, et al.. (2022). Meningioma systematic reviews and meta-analyses: an assessment of reporting and methodological quality. British Journal of Neurosurgery. 36(6). 678–685. 3 indexed citations

14.

Plaha, Puneet, Sophie Camp, Jonathan Cook, et al.. (2022). FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial. BMJ Open. 12(11). e064823–e064823. 12 indexed citations

15.

Coomans, Marijke B, Martin Taphoorn, Neil K. Aaronson, et al.. (2020). Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients. Neuro-Oncology Practice. 7(6). 668–675. 8 indexed citations

16.

Najafabadi, Amir H. Zamanipoor, Pim B. van der Meer, Florien Boele, et al.. (2020). The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient. Neuro-Oncology Advances. 3(1). vdaa169–vdaa169. 9 indexed citations

17.

Najafabadi, Amir H. Zamanipoor, Pim B. van der Meer, Florien Boele, et al.. (2020). Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients. Neurosurgery. 88(1). 155–164. 18 indexed citations

18.

Markusse, I.M., Linda Dirven, K. H. Han, et al.. (2014). Mortality in a Large Cohort of Patients with Early Rheumatoid Arthritis That Were Treated-to-Target for 10 Years.. Data Archiving and Networked Services (DANS). 66. 6 indexed citations

19.

Allaart, C.F., Linda Dirven, Shintaro Hirata, et al.. (2011). A Multi-Biomarker Disease Activity (Vectra DA) Algorithm Score for Rheumatoid Arthritis Predicts Radiographic Progression in the BeSt Study. Data Archiving and Networked Services (DANS). 1 indexed citations

20.

Heimans, L., Maries van den Broek, Linda Dirven, et al.. (2011). Body Mass Index Is Associated with Decreased Response to Initial and Delayed Treatment with Dose Escalated Infliximab in Patients with Recent Onset Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 63(10). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact